Hortensia
Álvarez Díaz
Hospital Universitario Virgen del Rocío
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen del Rocío (8)
2024
-
Elevated plasma levels of IP-10 and MIG are early predictors of loss of control among elite HIV controllers
Frontiers in Immunology, Vol. 15
2023
-
IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors
Frontiers in Immunology, Vol. 14
-
Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1
Journal of Infectious Diseases
2022
-
Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry
Internal and Emergency Medicine, Vol. 17, Núm. 3, pp. 761-775
-
Massive Release of CD9+ Microvesicles in Human Immunodeficiency Virus Infection, Regardless of Virologic Control
The Journal of infectious diseases, Vol. 225, Núm. 6, pp. 1040-1049
-
SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune Suppression
Microorganisms, Vol. 10, Núm. 1
2021
-
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252
2014
-
Efficacy and tolerability after 24 weeks of treatment with telaprevir, pegylated interferon and ribavirin in cirrhotic HIV-HCV coinfected subjects
Antiviral Research, Vol. 104, Núm. 1, pp. 59-61